Company Profile
Sofiva Genomics provides pre-pregnancy, prenatal, and newborn genetic testing and medical testing services in Taiwan and globally. The company offers reproductive testing services, including preimplantation genetic testing for aneuploidy (PGT-A), non-invasive preimplantation genetic testing for aneuploidy (niPGT-A), and preimplantation genetic testing for monogenic diseases (PGT-M)
Prenatal testing services, such as non-invasive prenatal screening, array, karyotyping, maternal serum screening for down syndrome, risk assessment for early/late-onset preeclampsia, folate metabolism genetic testing, congenital infection screening,carrier scan, thalassemia genetic testing, spinal muscular atrophy genetic testing, and fragile X syndrome genetic testing
Baby genetic testing comprising sensorineural hearing loss genetic testing. Its portfolio also includes congenital central hypoventilation syndrome genetic testing (CCHS), and congenital cytomegalovirus infection testing (CMV). Additionally, it offers cancer screening services, which includes human papillomavirus screening (HPV); and hereditary cancer testing services.
It also develops precision medicine genetic testing; and offers testing services to patients and carriers with rare disorders. Sofiva Genomics Co.,Ltd. was founded in 2012 and is based in Taipei, Taiwan.